TLDR
- INJ price surged ~9% to $4.40 after a major regulatory announcement
- Injective Institutional Services is now registered with the US SEC as a transfer agent
- The registration allows official securities ownership records to be maintained onchain
- Injective previously worked with Nomura’s Laser Digital, BlackRock, and Hamilton Lane
- Injective is also registered on ESMA’s Interim MiCA Register in Europe
Injective’s price climbed around 9% to $4.40 after its affiliate, Injective Institutional Services, officially registered with the US Securities and Exchange Commission as a transfer agent.
Transfer agents maintain official ownership records for securities and process changes to those records. The SEC allows registered transfer agents to use distributed ledger technology as their official master securityholder file. That means ownership records can now be maintained directly onchain.
This is a meaningful step for tokenized securities. Most blockchain systems record ownership onchain while the official legal record lives in a traditional database. That split can cause reconciliation problems between blockchain transactions and legacy systems.
Injective now has
SEC Transfer Agent Registration ✅
MiCA Whitepaper in the EU ✅
Injective Mint Alpha for Tokenizing Assets ✅
LG CNS and Korea’s largest trading firm POSCO selecting Injective for its tokenization pilot ✅
Institutional-grade RWAs are here on $INJ
— Injective 🥷 (@injective) August 20, 2026
Injective’s registration directly targets that gap. It can now maintain securities records on its own blockchain infrastructure, bringing the two systems closer together.
Regulated Infrastructure for Tokenized Assets
The registration works alongside Injective Mint, a tool that lets issuers create and manage assets with protocol-level compliance controls. Features include transfer restrictions based on holders and jurisdictions, role-based administration, address freezing, and controlled minting and redemption.
Injective has an existing track record in this space. Its network has supported tokenized institutional funds, public equities, private-company markets, and enterprise receivables. Past products involved Nomura’s Laser Digital, BlackRock, and Hamilton Lane.
Regulatory Push Extends to Europe
The registration is not limited to the US. Injective’s INJ MiCA white paper is listed on ESMA’s Interim MiCA Register after completing the required notification and publication process in Europe.
The company says both the US transfer agent registration and the European MiCA work are part of a broader effort to pair onchain financial infrastructure with the regulatory frameworks needed for institutional adoption.
The announcement came during an active week for US crypto regulation. President Donald Trump is scheduled to meet with the SEC, CFTC, and crypto firms including Ripple and Coinbase as the CLARITY Act faces delays. The SEC also released a new regulatory framework for crypto investment contracts this week.
Injective now joins a small group of US crypto organizations with a registered transfer agent function.
